LLMpediaThe first transparent, open encyclopedia generated by LLMs

International Parkinson and Movement Disorder Society

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 96 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted96
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
International Parkinson and Movement Disorder Society
NameInternational Parkinson and Movement Disorder Society
Formation1985
TypeProfessional society
Region servedGlobal
Leader titlePresident

International Parkinson and Movement Disorder Society The International Parkinson and Movement Disorder Society serves clinicians and researchers focusing on Parkinson's disease, dystonia, tremor, chorea, and related movement disorders by promoting research, education, and clinical care. The Society connects specialists across continents including Europe, North America, Asia, Africa, and Oceania, collaborating with hospitals, universities, funding bodies, and patient organizations to advance diagnosis and treatment.

History

Founded in 1985 amid growing global attention to idiopathic Parkinsonism and neurodegenerative disorders, the Society emerged as a successor to regional groups and congresses that drew investigators from institutions such as National Institutes of Health, Mayo Clinic, King's College London, Karolinska Institutet, and University of Toronto. Early leaders and contributors included investigators associated with landmark clinical trials and centers like Movement Disorder Society Congress, American Academy of Neurology, European Federation of Neurological Societies, World Health Organization, and referral centers at Johns Hopkins Hospital and Massachusetts General Hospital. Throughout the 1990s and 2000s the Society expanded programs by partnering with funding agencies like National Institute of Neurological Disorders and Stroke, philanthropic foundations connected to figures such as Michael J. Fox and institutions including Michael J. Fox Foundation, Parkinson's UK, and The Wellcome Trust.

Organization and Governance

Governance is structured with an elected board and committees mirroring governance models used by professional bodies such as American Neurological Association, Royal College of Physicians, Royal Society, Institute of Medicine, and university senates at Harvard University, University of Oxford, and Stanford University. Officers include a President, President-elect, Treasurer, Secretary, and councilors representing continental sections modeled after organizational frameworks from European Academy of Neurology, Asian Pacific Society of Neurology, Latin American Federation of Neurology, African Academy of Neurology, and national neurologic societies like Canadian Neurological Society. Advisory committees have included specialists affiliated with research centers such as Scripps Research Institute, Johns Hopkins University School of Medicine, UCL Queen Square Institute of Neurology, and Emory University School of Medicine.

Membership and Chapters

Membership comprises neurologists, neurosurgeons, movement disorder specialists, basic scientists, allied health professionals, and trainees linked to institutions such as Cleveland Clinic, University College London, Charité – Universitätsmedizin Berlin, Université de Montréal, and Keio University School of Medicine. The Society maintains regional chapters and sections paralleling entities like European Parkinson's Disease Association, Asian Parkinson's Disease Association, Latin American Parkinson's Network, Parkinson's Foundation, and national chapters in countries such as United States, United Kingdom, Japan, Brazil, Germany, India, and South Africa.

Research and Scientific Activities

The Society facilitates multicenter trials, collaborative studies, and translational research connecting investigators at Columbia University, Yale University, University of California, San Francisco, University of Pennsylvania, and University of Cambridge with biotechnology companies, regulatory agencies such as Food and Drug Administration, European Medicines Agency, and research funders including European Research Council and National Health and Medical Research Council. Research priorities have encompassed biomarkers, genetics, neuroimaging, neurophysiology, and therapeutics with links to consortia like Parkinson Progression Markers Initiative, initiatives inspired by work at Broad Institute, Wellcome Trust Sanger Institute, Cold Spring Harbor Laboratory, and technology centers at MIT, ETH Zurich, and Karolinska Institutet.

Education and Training

Educational programs include fellowship training guidelines, curricula for movement disorder fellowships, and workshops modeled on training programs at Mayo Clinic School of Graduate Medical Education, Johns Hopkins University, Toronto General Hospital, National Institute of Mental Health, and international exchange programs similar to partnerships between University of Melbourne and Osaka University. The Society organizes mentorship schemes, online learning modules, and simulation courses drawing on pedagogical resources from Coursera, university continuing medical education divisions at Columbia University Irving Medical Center, and specialist courses run at centers like Hôpital Pitié-Salpêtrière and Mount Sinai Hospital.

Publications and Conferences

Key publications and dissemination channels include a peer-reviewed journal, clinical practice guidelines, and proceedings from annual meetings similar to those of American Academy of Neurology Annual Meeting, World Congress of Neurology, European Academy of Neurology Congress, and specialty symposia held at venues like Palais des Congrès de Paris, McCormick Place, Messe Berlin, and Tokyo Big Sight. The Society collaborates with editorial boards and publishers linked to Nature Publishing Group, Elsevier, Wiley-Blackwell, Springer Nature, and specialty journals where researchers from University of Oxford, UCL, Stanford Medicine, and Harvard Medical School publish reports.

Advocacy and Global Initiatives

Advocacy efforts coordinate with patient organizations and global health actors including World Health Organization, United Nations, Global Parkinson's Advocacy Coalition, European Parkinson's Disease Association, and national health ministries in countries such as Australia, Canada, India, and South Africa to improve access to diagnosis, therapy, and rehabilitation. International initiatives align with campaigns and policy efforts resembling collaborations with Michael J. Fox Foundation, Parkinson's UK, American Parkinson Disease Association, Global Alliance for Chronic Diseases, and health systems reform efforts involving entities like Centers for Disease Control and Prevention and National Health Service.

Category:Neurology organizations